Lenalidomide/Revlimid Dose - Brand Name or Equal

The Oscar G. Johnson VA Medical Center in Iron Mountain, Michigan, through the Department of Veterans Affairs Veterans Integrated Service Network 12, is soliciting quotes for Lenalidomide/Revlimid medication in multiple dosages (2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg). Vendors must be certified pharmacies with Lenalidomide REMS program certification capable of dispensing the medication directly to veterans or to the VA pharmacy while adhering to strict regulatory requirements including patient enrollment, prescription verification, and comprehensive patient counseling. The procurement will be awarded using a Lowest Price Technically Acceptable (LPTA) evaluation methodology, meaning the VA will select the vendor offering the lowest cost among all proposals meeting technical requirements. Key deadlines include an initial quote submission deadline of November 21, 2025, at 3 PM CST (referenced in the first RFQ document) and a revised deadline of November 24, 2025, at 3 PM CST (referenced in the updated RFQ version 3.0). All quotes must be submitted to the contract specialist, Arneil Genus, at arneil.genus@va.gov.

This procurement carries no set-aside designations and is unrestricted, open to all qualified vendors meeting the Lenalidomide REMS certification requirements. The estimated annual usage includes 1,596 10mg capsules and 210 25mg capsules, with the contract period set for 12 months. Shipping to the VA Medical Center in Iron Mountain, Michigan, is provided on a Freight on Board (FOB) Destination basis, with shipping costs capped at $250. Invoicing will be processed electronically through the Tungsten Network, and vendors will submit quotes for the specific dosage quantities required. While the total contract value has not been disclosed, the scope encompasses direct dispensing to veterans or VA pharmacy and compliance with all Lenalidomide REMS program protocols and regulations for conditions including multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.